1. Evaluation of axial length to identify the effects of monocular 0.125% atropine treatment for pediatric anisometropia
- Author
-
Po-Hsiang Kao, Lan-Hsin Chuang, Chi-Chun Lai, Shin-Yi Chen, Ken-Kuo Lin, Jiahn-Shing Lee, Chiun-Ho Hou, Chueh-Tan Chen, Yu-Kai Kuo, Chi-Chin Sun, and Chun-Fu Liu
- Subjects
Medicine ,Science - Abstract
Abstract The aim of the study is to determine the effects of monocular 0.125% atropine daily treatment on the longer axial length (AL) eyes in children with pediatric anisometropia. This was a retrospective cohort study. The charts of children with anisometropia (aged 6–15 years) who had a > 0.2-mm difference in AL between the two eyes were reviewed. Children who received monocular treatment of 0.125% atropine in the eye with longer AL were included for final analysis. The main outcome measure was the difference in AL between the two eyes after treatment. Regression analysis was used to model the changes in AL according to the time of treatment in both eyes. Finally, forty eyes in 20 patients (mean age 10.2 years) were included in the analyses. During the treatment period, AL was controlled in the treated eyes (p = 0.389) but elongated significantly in the untreated eyes (p
- Published
- 2021
- Full Text
- View/download PDF